ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,064.20
0.91%
US Tech 100
17,173.20
1.85%
다우존스 지수
38,225.66
0.85%
Bitcoin
59,414.95
0.50%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. 4D Molecular Therapeutics Inc (FDMT)

  7. 4D Molecular Therapeutics Inc (FDMT) 뉴스

FDMT 4D Molecular Therapeutics Inc

26.38
0.99 (3.90%)
03 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
4D Molecular Therapeutics Inc FDMT 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.99 3.90% 26.38 08:32:39
개장가 저가 고가 종가 전일 종가
25.31 24.93 26.54 26.38 25.39
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
01/05/202421:00GLOBE4DMT Announces Presentations at ARVO 2024 Annual Meeting
28/03/202421:00GLOBE4DMT Announces Update on Regulatory Interactions and..
04/03/202422:00GLOBE4DMT to Participate in Upcoming Investor Conferences
01/03/202408:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/03/202407:15EDGAR2Form S-8 - Securities to be offered to employees in employee..
01/03/202406:12EDGAR2Form 8-K - Current report
01/03/202406:05GLOBE4DMT Reports Full Year 2023 Financial Results and..
22/02/202407:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/02/202410:51EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/02/202406:37EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/02/202422:43EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/02/202411:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/02/202410:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/02/202422:00GLOBE4DMT Presents Interim Data from 4D-310 INGLAXA Phase 1/2..
10/02/202406:56EDGAR2Form 8-K - Current report
09/02/202406:50EDGAR2Form 144 - Report of proposed sale of securities
09/02/202406:23EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
09/02/202406:22EDGAR2Form 144 - Report of proposed sale of securities
08/02/202410:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/02/202409:42EDGAR2Form 3/A - Initial statement of beneficial ownership of..
07/02/202413:27GLOBE4D Molecular Therapeutics Announces Pricing of Upsized..
06/02/202407:27EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
06/02/202406:35EDGAR2Form S-3ASR - Automatic shelf registration statement of..
06/02/202406:05GLOBE4D Molecular Therapeutics Announces Proposed Public Offering..
04/02/202407:00GLOBE4DMT Presents Positive Interim Data from Randomized Phase 2..
29/01/202422:00GLOBE4DMT to Host Corporate Webcast to Discuss Interim Data from..
26/01/202406:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/01/202406:50EDGAR2Form 144 - Report of proposed sale of securities
23/01/202422:00GLOBE4DMT Receives Rare Pediatric Disease Designation from FDA..
09/01/202406:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/01/202406:49EDGAR2Form 144 - Report of proposed sale of securities
05/01/202407:48EDGAR2Form 144 - Report of proposed sale of securities
04/01/202422:30EDGAR2Form 8-K - Current report
04/01/202422:00GLOBE4DMT Highlights Recent Clinical Pipeline Progress, Near-Term..
03/01/202422:01GLOBE4DMT and Arbor Biotechnologies Establish Partnership to..
22/12/202302:31DJN4D Molecular Shares Rise on FDA Designation for Wet AMD Drug
21/12/202322:00GLOBE4DMT Receives FDA Regenerative Medicine Advanced Therapy..
19/12/202307:16EDGAR2Form 144 - Report of proposed sale of securities
16/12/202307:24EDGAR2Form 144 - Report of proposed sale of securities
14/12/202306:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202306:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202306:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202306:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202306:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202322:00GLOBE4DMT to Present Interim 24 Week Data from Randomized Phase 2..
23/11/202306:20EDGAR2Form 8-K - Current report
15/11/202322:00GLOBE4DMT to Participate in Upcoming Investor Conferences
10/11/202306:23EDGAR2Form 8-K - Current report
10/11/202306:19GLOBE4DMT Reports Third Quarter 2023 Financial Results and..
02/11/202305:00GLOBE4DMT Presents Positive Interim Data from Phase 1/2 AEROW..

최근 히스토리

NASDAQ
FDMT
4D Molecular Therapeutics
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유